Severe asthma in obese patients: what to expect with Mepolizumab?
A. Da Cunha Fonseca (Vila Nova de Gaia, Portugal), D. Machado (Vila Nova de Gaia, Portugal), I. Pascoal (Vila Nova de Gaia, Portugal), I. Franco (Vila Nova de Gaia, Portugal), R. Lima (Vila Nova de Gaia, Portugal)
Source: International Congress 2022 – Asthma biologics in real life studies
Session: Asthma biologics in real life studies
Session type: Thematic Poster
Number: 2395
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Da Cunha Fonseca (Vila Nova de Gaia, Portugal), D. Machado (Vila Nova de Gaia, Portugal), I. Pascoal (Vila Nova de Gaia, Portugal), I. Franco (Vila Nova de Gaia, Portugal), R. Lima (Vila Nova de Gaia, Portugal). Severe asthma in obese patients: what to expect with Mepolizumab?. 2395
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|